Korean J Otolaryngol-Head Neck Surg.  2003 Dec;46(12):1070-1076.

Significance of MAGE A1-6 mRNA Expression in Sputa of the Head and Neck Cancer Patients: A Preliminary Report

Affiliations
  • 1Department of Otolaryngology, College of Medicine, Kosin University, Busan, Korea. kdlee@ns.kosinmed.or.kr
  • 2Department of Pathology, College of Medicine, Kosin University, Busan, Korea.
  • 3Department of Clinical Pathology, College of Medicine, Catholic University of Daegu, Korea.
  • 4Department of Immunology College of Medicine, Keimyung University, Daegu, Korea.

Abstract

BACKGROUND AND OBJECTIVES
We have reported that the expression of MAGE gene is specific to the mRNA level or protein level in head and neck cancer tissues. In this study, we investigated the applicability of MAGE gene to molecular diagnosis of head and neck cancer by detecting MAGE mRNA with common MAGE primers in sputa of patients. MATERIALS AND METHOD: Nested RT-PCR with MAGE common primers were designed by authors and were performed to detect MAGE 1, 2, 3, 4a, 4b, 5a, 5b, and 6 (MAGE A1-6) genes in sputa obtained from 22 cancer patients (17 squamous cell carcinoma of laryngopharynx, 2 lung metastsis after surgery for tongue and hypopharyngeal cancer, 2 neck metastasis from primary lung cancer, and 1 case of sarcoma of hypopharynx) and 40 normal persons. RESULTS: Of 17 sputa from squamous cell carcinoma patients, expression of MAGE mRNA was positive in 13 (76.5%) cases. MAGE was detected in 72.7% (8/11) of laryngeal cancer, 50% (1/2) of base of tongue cancer, and 100% in hypopharyngeal (2/2) and tonsillar cancer. According to T stage, T1, T2, T3, T4 was positive in 50% (2/4), 100% (5/5), 66.6% (2/3), and 80% (4/5) respectively. In case of primary lung cancer, metastatic lung cancer, and hypopharyngeal sarcoma, all expressed MAGE mRNA. Among 22 cancer patients, 81.8% (18/22) were positive. MAGE expression was detected in 5% (2/40) of the normal control. CONCLUSION: Nested RT-PCR with common MAGE primers was helpful for assessing the presence of cancer cell in the sputa of the respiratory tract. This examination can be used as a tumor marker for the screening of laryngopharyngeal cancers and early detection of recurrent cancers or lung metastasis after treatment.

Keyword

MAGE gene; Sputum; Tumor marker; Head and neck

MeSH Terms

Carcinoma, Squamous Cell
Diagnosis
Head and Neck Neoplasms*
Head*
Humans
Hypopharyngeal Neoplasms
Hypopharynx
Laryngeal Neoplasms
Lung
Lung Neoplasms
Mass Screening
Neck
Neoplasm Metastasis
Respiratory System
RNA, Messenger*
Sarcoma
Sputum
Tongue
Tongue Neoplasms
Tonsillar Neoplasms
RNA, Messenger
Full Text Links
  • KJORL-HN
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr